Researchers have been excited about Retatrutide , a groundbreaking dual agonist showing remarkable outcomes in clinical trials for weight management. It works by targeting both pathways : GLP-1 and GIP, that , when stimulated, assist regulate cravings and boost energy expenditure . Initial findings demonstrate noteworthy weight loss and likely impr